Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187297 · ClinicalTrials.gov registry record · NA
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
A NA study of Wrinkle and Lax Skin, sponsored by Bausch Health Americas.
- Recruiting
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT07187297: Recruiting NA study of Wrinkle and Lax Skin, sponsored by Bausch Health Americas.
NCT07187297 is a NA study of Wrinkle and Lax Skin that is actively recruiting participants, run by Bausch Health Americas. The registered enrollment target is 164 participants, above the 114-participant average among 25 other Wrinkle trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07187297, a NA study of Wrinkle and Lax Skin, is actively recruiting participants, sponsored by Bausch Health Americas.
- RECRUITING
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Primary Outcome
Proportion of participants with any improvement on iGAIS at Day 90 as assessed by independent blinded evaluators.
Conditions Studied
Interventions
- DEVICE Thermage FLX
Study Locations (1)
New York
- Union Square Laser Dermatology - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2025-10-31 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT07187297 shows while recruiting
NCT07187297 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, above the 114-participant average among 25 other Wrinkle trials with a reported enrollment target (44% higher).
The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Thermage FLX is the first listed.
NCT07187297 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07187297 about?
NCT07187297 is a clinical study titled "A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment". A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
What is the current status of trial NCT07187297?
This trial is currently recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2025-10-31. Estimated completion is 2027-03.
What conditions does trial NCT07187297 study?
This clinical trial studies the following conditions: Wrinkle, Lax Skin, Lines Skin.
What interventions are being tested in trial NCT07187297?
The interventions under investigation include: Thermage FLX (DEVICE).
Who is sponsoring clinical trial NCT07187297?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07187297 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07187297's enrollment target sits among peer trials
164 7th of 25 higher than 19 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI